Attached files
file | filename |
---|---|
EX-32 - Emergent BioSolutions Inc. | exhibit32_2.htm |
EX-32 - Emergent BioSolutions Inc. | exhibit32_1.htm |
EX-31 - Emergent BioSolutions Inc. | exhibit31_2.htm |
EX-31 - Emergent BioSolutions Inc. | exhibit31_1.htm |
EX-12 - Emergent BioSolutions Inc. | ex12.htm |
EX-10.5 - Emergent BioSolutions Inc. | exhibit10_5.htm |
EX-10.4 - Emergent BioSolutions Inc. | exhitbit10_4.htm |
EX-10.3 - Emergent BioSolutions Inc. | exhibit10_3.htm |
10-Q - Emergent BioSolutions Inc. | form10-q032018.htm |
EXHIBIT 10.2
Confidential Materials omitted and filed separately with the
Securities and Exchange Commission. Double asterisks denote omissions.
NSN 7540-01-152-8070 STANDARD FORM 30 (REV. 10-83)
PREVIOUS EDITION UNUSABLE 30-105 Prescribed by GSA
FAR (48 CFR) 53.243
1.
|
Decrease the number of doses for SubCLIN 2002 by [**] from [**]to [**].
|
2.
|
Decrease the cost and funding of SubCLIN 2002 by $[**] from $[**] to $[**].
|
3.
|
Add SubCLIN 2003 to cover the cost to purchase [**] doses at a lower rate of $[**].
|
4.
|
Increase and fund [**] doses on SubCLIN 2003 in the amount of $[**].
|
All changes will occur at no additional cost to the Government.
Section B – Supplies/Services
Option 1 Items
ITEM
|
SUPPLIES / SERVICES
|
QTY / UNIT
|
UNIT PRICE
|
EXTENDED PRICE
|
||||||
2002
|
BioThrax [**] product
[**] upon date of delivery:
[**] product at a unit price of $[**]
Delivery Address: Contractor's Facility
Delivery to be NLT [**]
|
[**] Doses
|
$
|
[
|
**]
|
$
|
[
|
**]
|
||
Line(s) Of Accounting:
939ZWUX 2642 2018 75-X-0956 5664711101 $[**]
|
ITEM
|
SUPPLIES / SERVICES
|
QTY / UNIT
|
UNIT PRICE
|
EXTENDED PRICE
|
||||||
2003
|
BioThrax [**] product
[**] upon date of delivery:
[**] product at a unit price of $[**]
Delivery Address: Contractor's Facility
Delivery to be NLT [**]
|
[**] Doses
|
$
|
[
|
**]
|
$
|
[
|
**]
|
||
Line(s) Of Accounting:
939ZWUX 2642 2018 75-X-0956 5664711101 $[**]
|